Position in MRK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,687,011
-$1,444,352 QoQ
Shares Held
52,039
-23.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#909
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Summit Global Investments holds $32,800,954 across 11 Drug Manufacturers - General names. MRK ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,407 | $12,482,469 | |
| 2 | MRK |
Merck & Co., Inc.
This page
|
52,039 | $6,687,011 | |
| 3 | ABBV |
AbbVie Inc.
|
11,572 | $2,911,978 | |
| 4 | JNJ |
Johnson & Johnson
|
9,808 | $2,490,937 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,712 | $1,479,694 | |
| 6 | PFE |
Pfizer Inc
|
60,517 | $1,457,249 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
23,680 | $1,364,441 | |
| 8 | AZN |
Astrazeneca PLC
|
6,543 | $1,240,683 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,687,011 | 52,039 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $8,131,363 | 67,598 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,502,090 | 71,272 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $11,131,803 | 132,632 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $12,329,170 | 155,750 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,989,268 | 89,007 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $19,898,387 | 200,024 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $17,337,091 | 152,669 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $18,001,262 | 145,406 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $15,906,176 | 120,547 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $22,360,656 | 205,106 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $17,152,396 | 166,609 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $19,551,104 | 169,435 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $18,560,267 | 174,455 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $22,504,321 | 202,833 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $17,785,846 | 206,524 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,795,880 | 206,163 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $21,731,845 | 264,861 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $11,600,536 | 151,364 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,551,409 | 100,538 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $12,748,058 | 163,920 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $12,982,810 | 168,411 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $16,134,633 | 197,245 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $15,636,828 | 188,509 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $14,760,911 | 190,882 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $2,155,627 | 28,017 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||